Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib.
作者信息
Plotkin Scott R, Blakeley Jaishri O
机构信息
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
出版信息
Neuro Oncol. 2024 Nov 4;26(11):1949-1950. doi: 10.1093/neuonc/noae137.
Abstract
摘要
相似文献
1
Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib.拓展与神经纤维瘤病2型相关的神经鞘瘤病患者的治疗选择：布加替尼取得了鼓舞人心的成果。
Neuro Oncol. 2024 Nov 4;26(11):1949-1950. doi: 10.1093/neuonc/noae137.
2
Brigatinib in -Related Schwannomatosis with Progressive Tumors.布加替尼治疗相关进行性肿瘤性神经鞘瘤病。
N Engl J Med. 2024 Jun 27;390(24):2284-2294. doi: 10.1056/NEJMoa2400985. Epub 2024 Jun 21.
3
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.2型神经纤维瘤病相关神经鞘瘤病的基因治疗：最新进展、挑战与未来方向
Oncol Ther. 2024 Jun;12(2):257-276. doi: 10.1007/s40487-024-00279-2. Epub 2024 May 17.
4
The comparable tumour microenvironment in sporadic and -related schwannomatosis vestibular schwannoma.散发性和与神经鞘瘤病相关的前庭神经鞘瘤中可比的肿瘤微环境。
Brain Commun. 2023 Jul 21;5(4):fcad197. doi: 10.1093/braincomms/fcad197. eCollection 2023.
5
Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.与2型神经纤维瘤病相关的神经鞘瘤病高危个体的基因检测、筛查及临床管理更新方案
Clin Genet. 2023 May;103(5):540-552. doi: 10.1111/cge.14310. Epub 2023 Mar 15.
6
-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.神经鞘瘤病及其他神经鞘瘤病相关：一项更新的遗传和流行病学研究。
J Med Genet. 2024 Aug 29;61(9):856-860. doi: 10.1136/jmg-2024-110065.
7
A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.INI1/SMARCB1蛋白表达的镶嵌模式可将施万细胞瘤病和与神经纤维瘤病2型（NF2）相关的外周神经鞘瘤与孤立性外周神经鞘瘤及与NF2相关的前庭神经鞘瘤区分开来。
Childs Nerv Syst. 2017 Jun;33(6):933-940. doi: 10.1007/s00381-017-3340-2. Epub 2017 Apr 1.
8
Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.65例施万细胞瘤病患者的脊髓神经鞘瘤与831例孤立性神经鞘瘤及102例2型神经纤维瘤病患者的临床特征比较：单机构回顾性研究
J Neurosurg Spine. 2016 Jan;24(1):145-54. doi: 10.3171/2015.3.SPINE141145. Epub 2015 Sep 25.
9
Schwannomatosis: a genetic and epidemiological study.神经鞘瘤病：一项遗传学和流行病学研究。
J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1215-1219. doi: 10.1136/jnnp-2018-318538. Epub 2018 Jun 16.
10
Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.神经鞘瘤病患者的表皮神经纤维密度明显降低，为诊断和鉴别诊断提供了主要参数。
Brain Pathol. 2020 Mar;30(2):386-391. doi: 10.1111/bpa.12780. Epub 2019 Sep 12.
本文引用的文献
1
-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.神经鞘瘤病及其他神经鞘瘤病相关：一项更新的遗传和流行病学研究。
J Med Genet. 2024 Aug 29;61(9):856-860. doi: 10.1136/jmg-2024-110065.
2
Brigatinib in -Related Schwannomatosis with Progressive Tumors.布加替尼治疗相关进行性肿瘤性神经鞘瘤病。
N Engl J Med. 2024 Jun 27;390(24):2284-2294. doi: 10.1056/NEJMoa2400985. Epub 2024 Jun 21.
3
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.美国 2016-2020 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2023 Oct 4;25(12 Suppl 2):iv1-iv99. doi: 10.1093/neuonc/noad149.
4
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.神经纤维瘤病2型相关神经鞘瘤病中良性肿瘤的放射治疗：一项对266例接受放疗患者的全国性研究显示恶性肿瘤/恶性进展显著增加。
Neurooncol Adv. 2023 Mar 11;5(1):vdad025. doi: 10.1093/noajnl/vdad025. eCollection 2023 Jan-Dec.
5
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.布立尼布通过抑制多种酪氨酸激酶而非 ALK，导致 NF2 缺失型脑膜瘤和神经鞘瘤的肿瘤缩小。
PLoS One. 2021 Jul 15;16(7):e0252048. doi: 10.1371/journal.pone.0252048. eCollection 2021.
6
Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.基于传统和系统生物学的神经纤维瘤病 2 型罕见肿瘤综合征药物发现。
PLoS One. 2018 Jun 13;13(6):e0197350. doi: 10.1371/journal.pone.0197350. eCollection 2018.
7
Neurofibromatosis type 2.2型神经纤维瘤病
Handb Clin Neurol. 2015;132:87-96. doi: 10.1016/B978-0-444-62702-5.00005-6.
8
The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2.神经纤维瘤病2型特定疾病生活质量问卷（NFTI-QOL）
J Neurol Surg B Skull Base. 2012 Apr;73(2):104-11. doi: 10.1055/s-0032-1301396.
Zotero 插件